Article
Pan-cancer analysis of tumor mutation burden sensitive tumors reveals tumor-specific subtypes and hub genes related to immune infiltration.
Journal of cancer research and clinical oncology - 1 Jul 2023
Wu Huan, Wang Hanchu, Chen Yue
Abstract excerpt
BACKGROUND: High tumor mutation burden (TMB) failed to serve as a favorable prognostic biomarker for immunotherapy across all tumors. This study aimed to explore TMB-sensitive tumors on a pan-cancer level and construct their immune infiltration phenotypes in TMB-high groups. METHODS: Pan-cancer patients were separated into TMB-high and TMB-low groups based on the median TMB values per tumor. TMB-related genes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
